Michael Curtis, eGenesis CEO
eGenesis brings kidney xenotransplants closer to the clinic
eGenesis’ genetically modified pig kidney transplant program reached preclinical proof-of-concept in a monkey model, and the company is in discussions with the FDA about what …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.